期刊文献+

血清Hcy和MMP-2水平检测在糖尿病肾病诊断中的应用价值 被引量:5

The Diagnosis Value of Hcy and MMP-2 in Patients of Early Diabetic Nephropathy
暂未订购
导出
摘要 目的:评价血清同型半胱氨酸(Hcy)和基质金属蛋白酶-2(MMP-2)检测在糖尿病肾病中诊断中的价值。方法:将91例糖尿病肾病患者随机分为无白蛋白尿组,微量白蛋白尿组和临床白蛋白尿组,另取同期门诊的健康体检者35例作为对照组,比较4组间Hcy和MMP-2水平的变化,应用Pearson's相关性分析和ROC曲线分析对各指标进行评价。结果:糖尿病肾病组患者Hcy水平明显升高,MMP-2水平明显降低,与对照组相比差异有统计学意义(P<0.05),且微量白蛋白尿组和临床白蛋白尿组与无蛋白尿组差异存在统计学意义(P<0.05);糖尿病患者的Hcy与蛋白尿排泄率呈正相关(r=0.57,P=0.024),MMP-2与蛋白尿排泄率呈负相关(r=-0.68,P=0.017);Hcy和MMP-2联合诊断的ROC曲线AUC面积大于各指标的单独诊断。结论:Hcy和MMP-2水平的变化与糖尿病肾病患者蛋白尿的排泄量有一定联系,可作为DN的早期监控和病变程度评估指标。 Objective:To evaluate homocysteine(Hcy) and matrix metalloproteinase-2(MMP-2) of early diagnosis in patients with diabetic nephropathy.Methods:91 patients were divided into without albuminuria group, microalbuminuria group and clinical albuminuria group, select health physical examination patient of 35 cases as control group, Hcy and MMP-2 were measured and compared with control group, evaluate the various indicators by Pearson's correlation analysis and ROC curve analysis.Results:Level of Hcy in patients with diabetic nephropathy group were increased significantly, and MMP-2 were decreased, compared with the control group significantly(P〈0.05), microalbuminuria group and clinical albuminuria group has highly statistically significant(P〈0.05)compared with control group. In DM patients, Hcy was positively correlation with UAER(r=0.57,P=0.024),but the MMP-2 had negative correlation with UAER (r=-0.68, P=0.017) . ROC areas of combined examination are more than each one.Conclusion:The change of Hcy and MMP-2 have certain contact on proteinuria emissions in patients with diabetic nephropathy, and which mightbe play a key role in the pathogenesis and progression of diabetic nephropathy patients.
作者 李颖
出处 《中国医药导刊》 2014年第5期891-892,共2页 Chinese Journal of Medicinal Guide
关键词 糖尿病肾病 HCY MMP-2 蛋白尿 Diabetic nephropathy Homocysteine Matrix metalloproteinase-2 Proteinuria
  • 相关文献

参考文献14

  • 1Tomaru T, StegerD J,LefterovaM l,et al.Adipocyte-specific expression 0fmurine resistin ismediated by synergism between peroxisome proliferator- activated receptor gamma and CCAAT/enhancer-binding proteins[J].J BiolChem,2009,28(4):611 -6125.
  • 2林辉,张江淮,阚明.糖尿病肾病患者血清胱抑素C检测的临床意义[J].中国医药导刊,2011,13(10):1713-1713. 被引量:5
  • 3中华医学会糖尿病学分会.中国Ⅱ型糖尿病防治指南(2007年版).中华内分泌代谢杂志,2008,.
  • 4徐晓萍,杜振东,朱清,张英,于嘉屏.尿GGT、尿mAlb及血清CysC与2型糖尿病早期肾损伤的关系[J].检验医学,2010,25(4):275-277. 被引量:11
  • 5Sieber J,Lindenmeyer MT,Kampe K,et al. Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids[J]. Am J Physiol Renal Physiol,2010;299(4) : F821 -F829.
  • 6Petrofsky J,Berk L,AI-Nakhli H.Tbe influence of autonomic dysfunction associated with aging and type 2 diabetes on daily life activities[J]. Exp Diabetes Res,2012;20( 12) : 6571-6778.
  • 7陶仕英,王晓梅,穆长征,刘萍.金属蛋白酶-9在糖尿病肾病发病机制中的作用[J].解剖学杂志,2009,32(1):35-37. 被引量:8
  • 8喻芳菊.三种糖尿病评估方法分析[J].实验与检验医学,2008,26(5):575-576. 被引量:14
  • 9KawaiT, MasakiT, Doi S, et al.PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta[J]. Lab Invest, 2009;89( 1 0): 47-58.
  • 10Stofkova A. Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity[J]. Endoer Regul, 2010;44( 1 ): 25-36.

二级参考文献48

共引文献43

同被引文献89

  • 1郭兵,肖瑛,万昌武,桂华珍,张国忠.糖尿病大鼠肾小管TGF-β_1和MAPK_(1/3)表达的动态观察[J].中国病理生理杂志,2004,20(9):1681-1685. 被引量:32
  • 2Olofssona LE,Olssona B,Lystiga T,et aL Prelimunary report:Zinc-alpha2 glyeoprotein genotype and serum levels are associated with serum lipids[J],MCE,2010,59(9):1316-1318.
  • 3Bing C,Bao Y,Jenkinsly,et al.Zinc-alpha2 glyeoproteina lipid mo- bilizing factor is expressed in adipocytes and is up-regulated in mice with cancer cachexia[J].Prec Nail Aead Sci USA,2004,101(8):2500-2505.
  • 4Lim SC,Liying DQ,Toy WC,ei al.Adipocytokine zinc α2 glyco- protein(ZAG)as a novel urinary biomarker for normo-albumin- uric diabetic nephropathy[J],Diabet Med,2012,29(7):945-949.
  • 5Roland Schmitt,Arnaud Marlier,Lloyd G.Cantley.Zag Expression during Aging Suppresses Proliferation after Kidney Injury[J].J Am Soc Nephrol,2008,19(12):2375-2383.
  • 6Kim SS,Song SH,Kim JL,et al.Clinical implication of urinary tu- bular markers in the early stage of nephropathywith type 2 diabet- ic patients.[J].Diabetes Res Clin Pract,2012,97(2):251-257.
  • 7Chou KM,Lee CC,Chen CH,et al.Clinical value of NGAL,L- FABP and albuminuria in predicting GFR decline in type 2 diabe- tes mellitus patients[J],PLoS One,2013,8(1):e54863.
  • 8Steven T.Russell and Michael J.Tisdale.Antidiabetic Properties of zinc-α-2-glycoprotein in ob/ob Mice[J].Endocrinology,2010,151?3):948-957.
  • 9Philipp A,Kralisch S,Bachmann A,et al.Serum levels of the adi- pokine zinc-α2-glycoprotein are increased in chronic hemodialysis[J].Metabolism,2011,60(5):669-672.
  • 10LelbachA,Muzes G,Feher J.Currentperspectivesof catabolic media-tors of canercachexia[J].Med Set Monit,2007,13(9):168-173.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部